Functional and Affective Effects of a Brief tDCS Intervention in Fibromyalgia and Chronic Fatigue Syndrome

NCT07573709 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-05-07

No results posted yet for this study

Summary

Functional and Affective Effects of a brief tDCS Intervention in Fibromyalgia and Chronic Fatigue Syndrome Fibromyalgia (FM) and chronic fatigue syndrome (CFS) are characterized by persistent, multidimensional symptoms arising from complex brain-body interactions that impair functioning and quality of life. Noninvasive neuromodulation techniques such as transcranial direct current stimulation (tDCS) have been proposed as adjunctive approaches to support short-term functional changes within distributed neural systems, although evidence remains limited and heterogeneous. The objective is to examine immediate pre-post changes in multidimensional clinical outcomes following a standardized tDCS protocol in patients with FM and CFS, and to explore potential diagnosis-related response patterns.

Conditions

  • Fibromyalgia (FM)
  • Chronic Fatigue Syndrome (CFS)

Interventions

DEVICE

Transcraneal Direct Current Electric Stimulation (tDCS)

It is an neuromodulation technic

DEVICE

Transcranial Direct Current Electric Stimulation (tDCS)

It is a neuromodulation technic

Sponsors & Collaborators

  • Hospital Donostia

    lead OTHER

Principal Investigators

  • Adolfo Lopez de Munain, Doctor · University Hospital of Donostia

  • PEDRO MONTOYA · UNIVERSITY OF BALEARIC ISLANDS, MALLORCA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2025-05-01
Completion
2025-05-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07573709 on ClinicalTrials.gov